These results suggest that upregulation of PrPC and inducers of α7nAChR, including nicotine and PNU-282987, may be useful neurotherapeutic strategies for neurodegenerative diseases, including Alzheimer's, Parkinson's, and prion diseases. Here, PRNP is linked to neurodegenerative disease.